Entrada Therapeutics, Inc. · NASDAQ:TRDA
MPM BioVentures 2014 GP LLC sold 86,482 Entrada Therapeutics, Inc. shares (Form 4)
Traded Sep 1 to Sep 3, 2026 · Filed Sep 3, 2026
From Sep 1 to Sep 3, 2026, MPM BioVentures 2014 GP LLC (10% owner) sold 86,482 Entrada Therapeutics, Inc. shares at an average US$7.14 for US$617K, leaving 4,144,952 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 86,482 shares
- Price
- US$7.14 average (US$7.06 to US$7.19)
- Value
- US$617K
- Holding after
- 4,144,952 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Sale | 29,088 | US$7.06 | 4,202,346 | Indirect |
| Sep 2, 2026 | Common Stock | Sale | 25,131 | US$7.19 | 4,177,215 | Indirect |
| Sep 3, 2026 | Common Stock | Sale | 32,263 | US$7.17 | 4,144,952 | Indirect |
Source
Related
- Entrada Therapeutics, Inc.
- MPM BioVentures 2014 GP LLC
- Entrada Therapeutics, Inc. shareholders
- Schedule 13D/A · Ansbert Gadicke · Sep 10, 2026
- Form 4 · MPM BioVentures 2018 GP LLC · Sep 9, 2026
- Form 4 · Mpm Bioventures 2018 (B), L.P. · Sep 9, 2026
- Form 4 · MPM BioVentures 2018 LLC · Sep 3, 2026
- Form 4 · Dowden Nathan J · Sep 3, 2026